/Companies

Block Biosciences

1 known investors

Find your way into Block Biosciences

Sign up to see every warm intro you have to Block Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Block Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Block Biosciences develops first-in-class therapeutics designed to intercept the spread of cancer to the brain by inhibiting a step in the purine biosynthesis pathway involved in brain metastasis. The company designs blood-brain-barrier-permeable inhibitors using a library of clinically-relevant brain metastasis models.

Investors · 1

Frequently asked questions

What does Block Biosciences do?
Block Biosciences develops first-in-class therapeutics designed to intercept the spread of cancer to the brain by inhibiting a step in the purine biosynthesis pathway involved in brain metastasis. The company designs blood-brain-barrier-permeable inhibitors using a library of clinically-relevant brain metastasis models.
Who are Block Biosciences's investors?
Block Biosciences's investors include FACIT (Fight Against Cancer Innovation Trust).